Retrophin, Inc. (OTCQB:RTRX) today announced that it has signed an
agreement with Novartis Pharma AG for an exclusive U.S. license for
Syntocinon™ Nasal Spray, the intranasal formulation of a synthetic
version of the naturally occurring peptide hormone oxytocin, for an
upfront payment of $5.0 million plus ... read more
FatWallet.com, where savvy shoppers share coupons and earn cash back at over 1,500 stores, presents holiday shoppers with Free Shipping Week, a one-stop resource to compare hundreds of retailers' free shipping offers, guaranteed for delivery before Christmas Day. Leading up to Free Shipping Day, the promotion features an entire week of free shipping discounts from hundreds of top retailers in which last minute holiday shoppers can stack additional savings with exclusive coupons and increased cash back. Free Shipping Day, which ... read more
Follett today announced a partnership with Simon & Schuster that makes more than 450 PreK-12 titles available in ebook format on Titlewave®, Follett's powerful collection development, search and ordering tool. Follett now offers more than 250,000 ebook titles through Titlewave to schools nationwide.
Simon & Schuster titles will span the full range of popular school titles from pre-school picture books to chapter books for early readers to higher-level fiction and nonfiction for young adults. Specific titles available include "Click, ... read more
Lpath, Inc. (Nasdaq: LPTN), the category leader in lipid-targeted therapeutics, is no longer actively participating in Pfizer's process to assign the exclusive option it has for a worldwide license to develop and commercialize Lpath's iSONEP(TM). Pfizer has informed Lpath that its offers were not competitive with other offers.
Lpath's CEO, Scott Pancoast commented, "We made a serious effort to reacquire this asset, and we continue to believe in iSONEP's prospects. However, given our commitment to fiscal ... read more
Centene Corporation (NYSE: CNC) announced today that it has signed a definitive agreement to purchase a majority interest in U.S. Medical Management, LLC. U.S. Medical Management, LLC, along with its affiliated entities ("USMM"), is a leading management services organization and provider of in-home health services for high acuity populations. Based in Troy, Michigan, USMM provides an integrated, physician-driven model which coordinates comprehensive care management for complex populations. USMM provides a continuum of in-home services including primary care, ... read more
OncoSec Medical Inc. (OTCQB: ONCS), a company developing its
advanced-stage ImmunoPulse DNA-based immunotherapy to treat solid
tumors, announced today that Dr. Robert H. Pierce has joined the company
as Chief Medical Officer.
A graduate of Yale College and the ... read more
Expect Labs, the San Francisco company that pioneered the field of anticipatory computing, today announced the general release of their much-anticipated MindMeld iPad app. MindMeld takes intelligent assistant technology to the next level by continuously understanding conversations and proactively finding related information in real-time. MindMeld represents the first publicly available application built using Expect Labs' anticipatory computing platform, and it serves as a showcase for the potential of this powerful technology. It is available for download today in the ... read more
FAIR LAWN, NJ -- (Marketwired) -- 12/12/13 -- Recently, Dr. Jody Bardash and Dr. William Scherer launched a new website for their dental practice, Dental Professionals of Fair Lawn. The New Jersey dentists say the website is designed to improve usability, as well as keep patients informed. It includes detailed biographies for each of the dental professionals at the practice, in addition to information about the services provided, such as:
Adult and Child Orthodontics ... read more
Senhwa Biosciences, Inc. has raised an additional $17 million USD in a Series B financing to drive its anticancer agents through critical clinical trials, the company announced today. The Taiwan and San Diego, CA based company closed the round with participation from existing and new investors including H&Q Asia Pacific, Morningside and China Investment & Development Co., Ltd. Proceeds from the financing will be used to support the continuing development of its first-in-class anticancer agents CX-5461 and CX-4945 and take ... read more
Rainbow Coral Corp. (OTCBB: RBCC) and its joint venture partner,
Therakine, Ltd., are pleased to announce that they have reached a major
new milestone in the development of a revolutionary new drug delivery
technology. This week, the companies reached terms to initiate Phase II
of research ... read more
BroadcastMed, Inc. a leading developer and distributor of digital
medical broadcasting content has announced the 2013 Best of
BroadcastMed award to recognize the top online digital presentations
created and posted this year by the world’s renowned physicians and
healthcare organizations. The medical community is invited to ... read more
Mazor Robotics Ltd. (TASE: MZOR) (NASDAQCM: MZOR), the developer of
Renaissance™, an innovative surgical guidance system and its
complementary products, announced today that it will be included in both
the Tel Aviv Stock Exchange (TASE) Top 75 Index (TA-75) and Top 100
Index (TA-100), effective December 15, ... read more
MphasiS, a leading IT services provider, today announced the appointment of Ajay Jotwani as Senior Vice President and Head of Infrastructure Services. Ajay will be part of MphasiS Leadership Team and report to Ganesh Ayyar, CEO MphasiS. He will be based in Santa Clara, California and will lead the global Infrastructure Services business unit.
Ajay joins MphasiS with more than 22 years of global business experience in leadership, organizational strategy, sales management, business development and operations. In the last 12 years, ... read more
AVG Technologies N.V. (NYSE: AVG), the provider of Internet and mobile security, privacy and optimization to 172 million active users, today announces the availability of AVG AntiVirus for Mac® to help protect MacBook®, iMac® and Mac Pro® users running OS X Mavericks (10.9) and Mountain Lion (10.8) from malware.
AVG AntiVirus for Mac is built on a powerful security engine that works in real time to detect and remove viruses and spyware that could infect your Mac or be passed on ... read more
CINCINNATI, OH -- (Marketwired) -- 12/12/13 -- Medpace Medical Device, a global, full-service medical device contract research organization (CRO) announced that MediTech Strategic Consultants B.V. will now be called Medpace Medical Device B.V., having completed integration activities. Medpace Medical Device B.V., long known throughout the medical device community for its excellent clinical trial conduct and regulatory/quality consultancy in Europe, will continue to be based in Vaals, NL, headquartering the European device operations.
MediTech joined Medpace Medical Device, a fully owned ... read more
Ipsen (Paris:IPN) (Euronext: IPN; ADR: IPSEY) announced today the
appointment of Dominique Brard as Executive Vice President in charge of
Human Resources of the Ipsen group, in place of Etienne de Blois.
Dominique will be a member ... read more
Ameritox(SM) announced today that it is sponsoring a series of webinars aimed at educating Indiana physicians about a new set of laws intended to curb prescription drug misuse and abuse.
In 2010, 711 people in Indiana died from accidental drug overdoses, and nationally the Centers for Disease Control have deemed prescription painkiller abuse an "epidemic." Modeled after Kentucky legislation aimed at stemming prescription drug abuse, Indiana is addressing the problem with an Emergency Prescribing Rule that will go into effect ... read more
(NYSE:AZN) and Bristol-Myers
Squibb Company (NYSE:BMY) today announced the U.S. Food and Drug
Administration’s (FDA) Endocrinologic and Metabolic Drugs Advisory
Committee (EMDAC) recommends the investigational medicine metreleptin
for the treatment of pediatric and adult patients with generalized
... read more
Synthetic Biologics, Inc. (NYSE MKT: SYN), a developer of product candidates focused on the prevention and treatment of serious infectious and other diseases, announced today the pricing of an underwritten public offering of 11,500,000 shares of common stock at a public offering price of $1.00 per share. The Company expects to receive $11,500,000 in gross proceeds, before deducting underwriting discounts and commissions and offering expenses payable by the Company. The Company has granted the underwriters a 45-day option to purchase ... read more
WASHINGTON, DC -- (Marketwired) -- 12/11/13 -- Helping patients make their medical records more portable so they can coordinate their care online across multiple providers is the goal of an innovative pilot project currently involving three states, five health information organizations, and three personal health record (PHR) companies.
The project, underway in California, Alaska and Oregon, is working to overcome physicians' concern that so-called "patient mediated exchange" may not be complete or accurate. It is aimed at ensuring that providers ... read more